Frank Mottola, SVP and Chief Technology Operations Officer at Supernus Pharmaceuticals (SUPN), sold about $1.95 million in company shares across five open market transactions in the past year. His latest sale was on March 9, 2026. These SUPN insider sales rank 3,554th among 11,678 individuals, below the average of $8.6 million per seller and 6.4 transactions. Mottola reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Performance Share Unit | 3750 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.01% |
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Common Stock | 3750 | $0.00 | 21,856.0000 | 56,552,741 | 20.71% | 0.01% |
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | F | Common Stock | 1793 | $54.73 | 20,063.0000 | 56,552,741 | 8.20% | 0.00% |
| March 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | S | Common Stock | 1623 | $53.65 | 18,440.0000 | 56,552,741 | 8.09% | 0.00% |
| Feb. 28, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Performance Share Unit | 3750 | $0.00 | 3,750.0000 | 56,552,741 | 9999.99% | 0.01% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Common Stock | 1875 | $0.00 | 19,083.0000 | 56,552,741 | 10.90% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | D | Restricted Stock Unit | 1875 | $0.00 | 1,875.0000 | 56,552,741 | 50.00% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | F | Common Stock | 977 | $50.69 | 18,106.0000 | 56,552,741 | 5.12% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Common Stock | 1250 | $0.00 | 17,878.0000 | 56,552,741 | 7.52% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | D | Restricted Stock Unit | 1125 | $0.00 | 3,375.0000 | 56,552,741 | 25.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | D | Restricted Stock Unit | 750 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | D | Restricted Stock Unit | 1250 | $0.00 | 2,500.0000 | 56,552,741 | 33.33% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Common Stock | 750 | $0.00 | 16,996.0000 | 56,552,741 | 4.62% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | F | Common Stock | 603 | $51.35 | 16,246.0000 | 56,552,741 | 3.58% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Common Stock | 1125 | $0.00 | 16,849.0000 | 56,552,741 | 7.15% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | F | Common Stock | 368 | $50.86 | 16,628.0000 | 56,552,741 | 2.17% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | F | Common Stock | 670 | $50.86 | 17,208.0000 | 56,552,741 | 3.75% | 0.00% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Restricted Stock Unit | 3000 | $0.00 | 3,000.0000 | 56,552,741 | 9999.99% | 0.01% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | A | Employee Stock Option (Right to Buy) | 13500 | $0.00 | 13,500.0000 | 56,552,741 | 9999.99% | 0.02% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Common Stock | 5000 | $39.40 | 20,496.0000 | 56,552,741 | 32.27% | 0.01% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.03% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Employee Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.01% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | S | Common Stock | 15000 | $50.47 | 15,496.0000 | 56,552,741 | 49.19% | 0.03% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Common Stock | 15000 | $25.30 | 30,496.0000 | 56,552,741 | 96.80% | 0.03% |
| Dec. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | S | Common Stock | 5000 | $50.22 | 15,496.0000 | 56,552,741 | 24.40% | 0.01% |
| Sept. 12, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Employee Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 55,958,537 | 50.00% | 0.01% |
| Sept. 12, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | M | Common Stock | 5000 | $39.40 | 20,496.0000 | 55,958,537 | 32.27% | 0.01% |
| Sept. 12, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Chief Tech. Ops. Officer | S | Common Stock | 5000 | $45.87 | 15,496.0000 | 55,958,537 | 24.40% | 0.01% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 14000 | $12.98 | 29,496.0000 | 55,958,537 | 90.35% | 0.03% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S | Common Stock | 14000 | $44.51 | 15,496.0000 | 55,958,537 | 47.46% | 0.03% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Employee Stock Option (Right to Buy) | 14000 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.03% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Units | 2625 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 2625 | $0.00 | 16,507.0000 | 55,958,537 | 18.91% | 0.00% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 1356 | $39.11 | 15,151.0000 | 55,958,537 | 8.21% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 610 | $33.05 | 14,827.0000 | 55,958,537 | 3.95% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 337 | $33.05 | 15,437.0000 | 55,958,537 | 2.14% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 945 | $33.05 | 13,882.0000 | 55,958,537 | 6.37% | 0.00% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Units | 3750 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.01% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 2010 | $0.00 | 14,909.0000 | 55,958,537 | 15.58% | 0.00% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 976 | $39.48 | 13,933.0000 | 55,958,537 | 6.55% | 0.00% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 3750 | $0.00 | 17,683.0000 | 55,958,537 | 26.91% | 0.01% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 1909 | $39.48 | 15,774.0000 | 55,958,537 | 10.80% | 0.00% |
| Feb. 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Units | 2010 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Unit | 1875 | $0.00 | 3,750.0000 | 55,958,537 | 33.33% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 1125 | $0.00 | 9,576.0000 | 55,958,537 | 13.31% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 552 | $39.15 | 9,024.0000 | 55,958,537 | 5.76% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 750 | $0.00 | 9,774.0000 | 55,958,537 | 8.31% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 1250 | $0.00 | 11,024.0000 | 55,958,537 | 12.79% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 1875 | $0.00 | 12,899.0000 | 55,958,537 | 17.01% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Units | 1125 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Unit | 750 | $0.00 | 750.0000 | 55,958,537 | 50.00% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,958,537 | 25.00% | 0.00% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 55,958,537 | 9999.99% | 0.01% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 55,958,537 | 9999.99% | 0.04% |
| Feb. 17, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Units | 2625 | $0.00 | 2,625.0000 | 55,958,537 | 9999.99% | 0.00% |
| Feb. 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Units | 2010 | $0.00 | 2,010.0000 | 55,958,537 | 9999.99% | 0.00% |
| Feb. 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Units | 3750 | $0.00 | 3,750.0000 | 55,958,537 | 9999.99% | 0.01% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Units | 1125 | $0.00 | 1,125.0000 | 55,958,537 | 9999.99% | 0.00% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.03% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S | Common Stock | 15000 | $36.98 | 8,200.0000 | 56,016,350 | 64.66% | 0.03% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 15000 | $9.13 | 23,200.0000 | 56,016,350 | 182.93% | 0.03% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 990 | $0.00 | 8,239.0000 | 55,506,828 | 13.66% | 0.00% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Unit | 990 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.00% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 460 | $27.94 | 7,779.0000 | 55,506,828 | 5.58% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 1875 | $0.00 | 8,186.0000 | 55,506,828 | 29.71% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Unit | 1875 | $0.00 | 5,625.0000 | 55,506,828 | 25.00% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 937 | $29.06 | 7,249.0000 | 55,506,828 | 11.45% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 55,506,828 | 9999.99% | 0.05% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 750 | $0.00 | 6,646.0000 | 55,506,828 | 12.72% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Unit | 990 | $0.00 | 990.0000 | 55,506,828 | 9999.99% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 335 | $27.94 | 6,311.0000 | 55,506,828 | 5.04% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Unit | 750 | $0.00 | 1,500.0000 | 55,506,828 | 33.33% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Restricted Stock Unit | 5000 | $0.00 | 5,000.0000 | 55,506,828 | 9999.99% | 0.01% |
| Nov. 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Employee Stock Option (Right to Buy) | 2000 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Nov. 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 2000 | $9.24 | 6,791.0000 | 61,679,800 | 41.74% | 0.00% |
| Nov. 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S | Common Stock | 1110 | $28.13 | 5,681.0000 | 61,679,800 | 16.35% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | A | Common Stock | 750 | $0.00 | 9,517.0000 | 61,679,800 | 8.55% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | F | Common Stock | 289 | $38.57 | 9,228.0000 | 61,679,800 | 3.04% | 0.00% |
| March 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | S | Common Stock | 4780 | $35.99 | 4,737.0000 | 61,679,800 | 50.23% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Restricted Stock Units | 7500 | $0.00 | 7,500.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Employee Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,679,800 | 9999.99% | 0.05% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Common Stock | 750 | $0.00 | 9,517.0000 | 61,679,800 | 8.55% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F | Common Stock | 753 | $38.74 | 8,191.0000 | 61,679,800 | 8.42% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Performance Share Unit | 1500 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M | Common Stock | 1500 | $0.00 | 8,944.0000 | 61,679,800 | 20.15% | 0.00% |
| Jan. 12, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | A | Performance Share Unit | 1500 | $0.00 | 1,500.0000 | 61,679,800 | 9999.99% | 0.00% |